This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Centre National De La Recherche Scientifique, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2012-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Paris, FR (2012)
- Le Kremlin Bicetre, FR (2018 - 2021)
Company Filing History:
3 out of 1,853 
2 out of 5,383 
2 out of 8,845 
Years Active: 2012-2021
Title: Nathalie Cartier-Lacave: Innovator in Alzheimer's Disease Research
Introduction
Nathalie Cartier-Lacave is a prominent inventor based in Le Kremlin Bicetre, France. She has made significant contributions to the field of medical research, particularly in the study of Alzheimer's disease. With a total of 3 patents to her name, her work has the potential to advance our understanding and treatment of this debilitating condition.
Latest Patents
Among her latest patents is a groundbreaking invention related to an Alzheimer's disease animal model. This invention involves a vector comprising a nucleic acid sequence that encodes the APP protein and/or the PS1 protein or variants thereof. The invention also includes a method for inducing Alzheimer's disease in an animal using this vector, leading to the development of an animal model that exhibits the characteristics of Alzheimer's disease.
Career Highlights
Nathalie has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université de Paris. Her research has focused on innovative approaches to understanding the mechanisms of Alzheimer's disease, contributing valuable insights to the scientific community.
Collaborations
Throughout her career, Nathalie has collaborated with notable colleagues, including Jerome Braudeau and Nicole Deglon. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.
Conclusion
Nathalie Cartier-Lacave is a dedicated inventor whose work in Alzheimer's disease research is paving the way for future advancements in medical science. Her innovative patents and collaborations highlight her commitment to improving our understanding of this complex disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile